Lumos Pharma, Inc. Common Stock
LUMO
LUMO was delisted on the 11th of December, 2024.
124 hedge funds and large institutions have $754M invested in Lumos Pharma, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 40 increasing their positions, 31 reducing their positions, and 11 closing their positions.
218% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 11
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
55% more capital invested
Capital invested by funds: $486M → $754M (+$268M)
29% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 31
24% more funds holding
Funds holding: 100 → 124 (+24)
5% less call options, than puts
Call options by funds: $88.7M | Put options by funds: $93.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GAM
Gotham Asset Management
New York
|
+$36.1M |
| 2 |
O
OrbiMed
New York
|
+$21.2M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$4.74M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.92M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$3.14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
PointState Capital
New York
|
-$8.44M |
| 2 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$3.44M |
| 3 |
State Street
Boston,
Massachusetts
|
-$2.84M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$2.84M |
| 5 |
Barclays
London,
United Kingdom
|
-$2.32M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCM
126
Cadence Capital Management
Boston,
Massachusetts
| – | -$752K | -2,102 | Closed |
|
|
MLICM
127
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$580K | -1,620 | Closed |
|
|
CAN
128
Cetera Advisor Networks
El Segundo,
California
| – | -$440K | -1,223 | Closed |
|
|
PCC
129
Park Circle Company
Baltimore,
Maryland
| – | -$398K | -1,111 | Closed |
|
|
PAM
130
Paradigm Asset Management
New York
| – | -$386K | -1,078 | Closed |
|
131
D.E. Shaw & Co
New York
| – | -$313K | -876 | Closed |
|
132
Lazard Asset Management
New York
| – | -$265K | -741 | Closed |
|
|
PAG
133
Private Advisor Group
Morristown,
New Jersey
| – | -$238K | -665 | Closed |
|
134
Simplex Trading
Chicago,
Illinois
| – | -$126K | -326 | Closed |
|
|
NPC
135
National Planning Corporation
El Segundo,
California
| – | -$7.59K | -22 | Closed |
|
LUMO Hedge Fund Activity: Q1 2015 in Review
124 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q1 2015, worth a combined $754M — up 55% from $486M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new LUMO positions and 11 closed out — a net gain of 24 holders — while 40 added to existing stakes and 31 trimmed.
The largest buyer was Gotham Asset Management, opening a new position worth an estimated $36.1M. The largest seller was PointState Capital, cutting an estimated $8.44M.
- 124 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q1 2015, up from 100 in Q4 2014.
- Funds reported $754M of Lumos Pharma, Inc. Common Stock stock for Q1 2015, up 55% quarter-over-quarter.
- 35 funds opened new Lumos Pharma, Inc. Common Stock positions in Q1 2015 and 11 closed out, a net change of +24 holders.
- The largest Lumos Pharma, Inc. Common Stock buyer in Q1 2015 was Gotham Asset Management, an estimated $36.1M added.
- The largest Lumos Pharma, Inc. Common Stock seller in Q1 2015 was PointState Capital, an estimated $8.44M sold.
Based on aggregated 13F filings for Q1 2015.